Infradiagnóstico de la enfermedad pulmonar obstructiva crónica en mujeres: cuantificación del problema, determinantes y propuestas de acción

[1]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[2]  M. Miravitlles,et al.  Impairment of quality of life in women with chronic obstructive pulmonary disease. , 2012, Respiratory medicine.

[3]  Pepi Valverde,et al.  [Treating COPD in chronic patients in a primary-care setting]. , 2011, Archivos de bronconeumologia.

[4]  Luis Fernando Sanchez Mendez,et al.  Hospital de día de enfermedades respiratorias: impacto sobre la tasa de ingresos hospitalarios por exacerbaciones de la enfermedad pulmonar obstructiva crónica , 2011 .

[5]  J. Soriano,et al.  [Geographical variations in the prevalence of COPD in Spain: relationship to smoking, death rates and other determining factors]. , 2010, Archivos de bronconeumologia.

[6]  M. Miravitlles,et al.  Diferencias geográficas en la prevalencia de EPOC en España: relación con hábito tabáquico, tasas de mortalidad y otros determinantes , 2010 .

[7]  Y. Heijdra,et al.  Increasing Evidence for Gender Differences in Chronic Obstructive Pulmonary Disease , 2010, Women's health.

[8]  I. Tillie‐Leblond,et al.  [Are there specific characteristics of COPD in women?]. , 2010, Revue des maladies respiratoires.

[9]  J. Gelberg,et al.  Overcoming Gaps in the Management of Chronic Obstructive Pulmonary Disease in Older Patients , 2010, Drugs & aging.

[10]  S. Rennard,et al.  Treatment of Chronic Obstructive Pulmonary Disease with Roflumilast, a New Phosphodiesterase 4 Inhibitor , 2010, COPD.

[11]  J. Soriano,et al.  Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007 , 2009, European Respiratory Journal.

[12]  D. Price,et al.  Screening for and early detection of chronic obstructive pulmonary disease , 2009, The Lancet.

[13]  J. Soriano,et al.  Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities , 2009, Thorax.

[14]  J. Soriano,et al.  Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey , 2009, ATS 2009.

[15]  C. Côté,et al.  Diagnosis and treatment considerations for women with COPD , 2009, International journal of clinical practice.

[16]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[17]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[18]  M. Miravitlles,et al.  Datos epidemiológicos de EPOC en España , 2007 .

[19]  Cesar G Victora,et al.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.

[20]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[21]  Rafael Gabriel,et al.  Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. , 2005, Respiratory medicine.

[22]  R. Pauwels,et al.  Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. , 2004, Respiratory medicine.

[23]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[24]  Anita B. Varkey.  Chronic obstructive pulmonary disease in women: exploring gender differences , 2004, Current opinion in pulmonary medicine.

[25]  M. Miravitlles,et al.  Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. , 2000, Chest.

[26]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[27]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[28]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[29]  R. Molina.  Rdl 2/2006 sobre los Expendedores de Tabaco y Timbre, de Modificación de los Tipos del Impuesto sobre las Labores del Tabaco y se Modifica la Ley 28/2005 , 2014 .

[30]  S. Stanojevic,et al.  THE GLOBAL LUNG FUNCTION 2012 EQUATIONS Report of the Global Lung Function Initiative (GLI), ERS Task Force to establish improved Lung Function Reference Values. , 2012 .

[31]  Luis Fernando Casas Méndez,et al.  [Respiratory day hospital: Impact on the rate of hospital admissions due to chronic obstructive pulmonary disease exacerbations]. , 2011, Medicina clinica.

[32]  I. Tillie‐Leblond,et al.  [Are there specific characteristics of COPD in women?]. , 2010, Revue des maladies respiratoires.

[33]  C. C. Macario,et al.  EPOC en la mujer , 2010 .

[34]  M. Miravitlles,et al.  [The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary]. , 2009, Archivos de bronconeumologia.

[35]  C. C. Macario,et al.  Enfermedad pulmonar obstructiva crónica: ¿qué hay más allá del índice BODE? , 2009 .

[36]  G. Valdivia,et al.  Diagnostic labeling of COPD in five Latin American cities. , 2007, Chest.

[37]  Carmen Rodríguez Blas.  Encuesta Nacional de Salud , 2007 .

[38]  M. Fernández,et al.  Problemas con el diagnóstico de la EPOC en atención primaria , 2006 .

[39]  M. Miravitlles,et al.  [Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care]. , 2006, Archivos de bronconeumologia.

[40]  J. Mackay,et al.  The Tobacco Atlas , 2002 .